Source: PIB
Context: The Anusandhan National Research Foundation (ANRF), in collaboration with the ICMR and the Bill & Melinda Gates Foundation, has launched the Maha MedTech Mission to boost India’s medical technology ecosystem.
About Maha MedTech Mission:
What it is?
- The Mission for Advancement in High-Impact Areas (MAHA)–MedTech is a national initiative to accelerate innovation, manufacturing, and commercialization of cutting-edge medical technologies in India, enhancing access and affordability in healthcare.
Organisations involved:
- Jointly launched by the Anusandhan National Research Foundation (ANRF), the Indian Council of Medical Research (ICMR), and the Bill & Melinda Gates Foundation.
Aim:
- To reduce India’s dependence on high-cost medical imports, strengthen domestic capacity, and ensure equitable access to affordable and high-quality medical devices and diagnostics aligned with national health priorities such as tuberculosis, cancer, and neonatal care.
Key Features:
- Funding Support: ₹5–25 crore per project (up to ₹50 crore for exceptional cases) for startups, MSMEs, academic, hospital, and industry collaborations.
- Broad Scope: Covers devices, diagnostics, implants, AI/ML-based tools, robotics, and assistive technologies.
- Enabling Frameworks: Includes Patent Mitra for IP protection, MedTech Mitra for regulatory clearances, and a Clinical Trial Network for validation.
- Two-Stage Selection: Concept notes (Sept–Nov 2025) followed by full proposals (from Dec 2025).
Significance:
- Strengthens India’s Atmanirbhar Bharat vision in medical technology.
- Promotes industry–academia collaboration and research translation from lab to market.
